4.7 Article

Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: Enzymes

Stephen P. H. Alexander et al.

BRITISH JOURNAL OF PHARMACOLOGY (2015)

Review Cell Biology

Fasting: Molecular Mechanisms and Clinical Applications

Valter D. Longo et al.

CELL METABOLISM (2014)

Review Oncology

Determining the optimal dose in the development of anticancer agents

Ron H. J. Mathijssen et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Article Biochemistry & Molecular Biology

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

Adam J. Pawson et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Cell Biology

Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy

Changhan Lee et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

Article Oncology

Global Cancer Statistics

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2011)

Article Surgery

Pre-operative dietary restriction is feasible in live-kidney donors

Tessa M. van Ginhoven et al.

CLINICAL TRANSPLANTATION (2011)

Article Gastroenterology & Hepatology

Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice

Leo R. Fitzpatrick et al.

GUT PATHOGENS (2011)

Article Pharmacology & Pharmacy

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

J. C. McGrath et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Article Pharmacology & Pharmacy

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

Carol Kilkenny et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Article Cell Biology

Fasting and cancer treatment in humans: A case series report

Fernando M. Safdie et al.

AGING-US (2009)

Article Gastroenterology & Hepatology

The Use of Preoperative Nutritional Interventions to Protect Against Hepatic Ischemia-Reperfusion Injury

Tessa M. van Ginhoven et al.

LIVER TRANSPLANTATION (2009)

Review Cell Biology

Dietary factors, hormesis and health

Mark P. Mattson

AGEING RESEARCH REVIEWS (2008)

Review Cell Biology

Hormesis defined

Mark P. Mattson

AGEING RESEARCH REVIEWS (2008)

Article Multidisciplinary Sciences

Starvation-dependent differential stress resistance protects normal but not cancer COS against high-dose chemotherapy

Lizzia Raffaghello et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Pharmacology & Pharmacy

Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2

Christoph Koehle et al.

BIOCHEMICAL PHARMACOLOGY (2007)

Review Medical Laboratory Technology

Insights, challenges, and future directions in irinogenetics

Tae Won Kim et al.

THERAPEUTIC DRUG MONITORING (2007)

Review Biochemistry & Molecular Biology

Collateral damage in cancer chemotherapy - Oxidative stress in nontargeted tissues

Yumin Chen et al.

MOLECULAR INTERVENTIONS (2007)

Article Pharmacology & Pharmacy

The role of SN-38 exposure, UGT1A1*28 polymorphism, and baseline bilirubin level in predicting severe irinotecan toxicity

Roshni P. Ramchandani et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2007)

Review Pharmacology & Pharmacy

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

SS Cao et al.

EXPERT OPINION ON PHARMACOTHERAPY (2006)

Review Oncology

Role of pharmacogenetics in irinotecan therapy

FA de Jong et al.

CANCER LETTERS (2006)